2024 |
Travere Therapeutics Inc
|
Independent Director |
242.3 K |
- |
2024 |
CARGO Therapeutics Inc
|
Chairman of the Board |
- |
- |
2024 |
AnaptysBio Inc
|
Chairman of the Board |
- |
- |
2023 |
CARGO Therapeutics Inc
|
Chairman of the Board |
818.6 K |
- |
2023 |
AnaptysBio Inc
|
Chairman of the Board |
338.1 K |
- |
2023 |
Atreca Inc - Ordinary Shares - Class A
|
Principal Financial Officer ,Director, President a |
- |
- |
2023 |
Travere Therapeutics Inc
|
Independent Director |
- |
- |
2022 |
Seagen Inc
|
Independent Director |
468.5 K |
- |
2022 |
Travere Therapeutics Inc
|
Independent Director |
321.6 K |
13.1 % |
2022 |
CARGO Therapeutics Inc
|
Chairman of the Board |
- |
- |
2022 |
Atreca Inc - Ordinary Shares - Class A
|
Director, President and Chief Executive Officer |
- |
- |
2021 |
Travere Therapeutics Inc
|
Independent Director |
284.2 K |
13.6 % |
2021 |
Atreca Inc - Ordinary Shares - Class A
|
Director, President and Chief Executive Officer |
- |
- |
2020 |
Travere Therapeutics Inc
|
Independent Director |
250.2 K |
2.9 % |
2020 |
Atreca Inc - Ordinary Shares - Class A
|
Director, President and Chief Executive Officer |
- |
- |
2019 |
Travere Therapeutics Inc
|
Independent Director |
243.2 K |
-37.9 % |
2019 |
Atreca Inc - Ordinary Shares - Class A
|
Director, President and Chief Executive Officer |
- |
- |
2018 |
Travere Therapeutics Inc
|
Independent Director |
391.5 K |
24.0 % |
2018 |
Atreca Inc - Ordinary Shares - Class A
|
Director, President and Chief Executive Officer |
- |
- |
2017 |
Travere Therapeutics Inc
|
Independent Director |
315.8 K |
- |
2016 |
Travere Therapeutics Inc
|
Independent Director |
- |
- |